{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["flavonoids", "inflammatory process", "methyldopa", "placenta"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33652665", "DateCompleted": {"Year": "2021", "Month": "04", "Day": "06"}, "DateRevised": {"Year": "2021", "Month": "04", "Day": "06"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "02", "Day": "26"}], "Language": ["eng"], "ELocationID": ["1259", "10.3390/molecules26051259"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "26", "Issue": "5", "PubDate": {"Year": "2021", "Month": "Feb", "Day": "26"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Combined Effects of Methyldopa and Flavonoids on the Expression of Selected Factors Related to Inflammatory Processes and Vascular Diseases in Human Placenta Cells-An In Vitro Study.", "Abstract": {"AbstractText": ["The aim of the study was to investigate combined effects of flavonoids (apigenin, baicalein, chrysin, quercetin, and scutellarin) and methyldopa on the expression of selected proinflammatory and vascular factors in vitro for prediction of their action in pregnancy-induced hypertension. The research was conducted on a trophoblast-derived human choriocarcinoma cell line and a primary human umbilical vein endothelial cell line. Cytotoxicity of compounds in selected concentrations (20, 40, and 100 \u00b5mol) was measured using the MTT test and the concentration of 40 \u00b5mol was selected for further analysis. Subsequently, their effects with methyldopa on the expression of selected markers responsible for inflammation (TNF-\u03b1; IL-1\u03b2; IL-6) and vascular effects (hypoxia-inducible factor 1\u03b1-HIF-1\u03b1; placental growth factor-PIGF; transforming growth factor \u03b2-TGF-\u03b2; vascular endothelial growth factor-VEGF) at the mRNA and protein levels were assessed. It was found that every combined administration of a flavonoid and methyldopa in these cells induced a down-regulating effect on all tested factors, except PIGF, especially at the mRNA expression level. As hypertension generally raises TNF-\u03b1, IL-1\u03b2, IL-6, HIF-1\u03b1, TGF-\u03b2, and VEGF mRNA expression and/or protein levels, the results obtained in the studied model may provide a positive prognostic factor for such activity in vivo."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Phytochemistry, Institute of Natural Fibres and Medicinal Plants, Kolejowa 2, 62-064 Plewiska, Poland."}], "LastName": "Bogacz", "ForeName": "Anna", "Initials": "A"}, {"Identifier": ["0000-0002-1252-6523"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Phytochemistry, Institute of Natural Fibres and Medicinal Plants, Kolejowa 2, 62-064 Plewiska, Poland."}, {"Identifier": [], "Affiliation": "Department of Pharmacology, Poznan University of Medical Sciences, Rokietnicka 5a, 60-806 Pozna\u0144, Poland."}], "LastName": "Miko\u0142ajczak", "ForeName": "Przemys\u0142aw \u0141", "Initials": "P\u0141"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Stem Cells and Regenerative Medicine, Institute of Natural Fibres and Medicinal Plants, Kolejowa 2, 62-064 Plewiska, Poland."}], "LastName": "Wolek", "ForeName": "Marlena", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Stem Cells and Regenerative Medicine, Institute of Natural Fibres and Medicinal Plants, Kolejowa 2, 62-064 Plewiska, Poland."}], "LastName": "G\u00f3rska", "ForeName": "Aleksandra", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Poznan University of Medical Sciences, Rokietnicka 5a, 60-806 Pozna\u0144, Poland."}], "LastName": "Szulc", "ForeName": "Micha\u0142", "Initials": "M"}, {"Identifier": ["0000-0003-2305-3116"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, Institute of Natural Fibres and Medicinal Plants, WojskaPolskiego 71b, 60-630 Pozna\u0144, Poland."}], "LastName": "O\u017carowski", "ForeName": "Marcin", "Initials": "M"}, {"Identifier": ["0000-0002-2389-0689"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Poznan University of Medical Sciences, Rokietnicka 5a, 60-806 Pozna\u0144, Poland."}], "LastName": "Kujawski", "ForeName": "Rados\u0142aw", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Stem Cells and Regenerative Medicine, Institute of Natural Fibres and Medicinal Plants, Kolejowa 2, 62-064 Plewiska, Poland."}, {"Identifier": [], "Affiliation": "Department of General Pharmacology and Pharmacoeconomics, Pomeranian Medical University in Szczecin, \u017bo\u0142nierska 48, 70-204 Szczecin, Poland."}], "LastName": "Czerny", "ForeName": "Bogus\u0142aw", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Gynecology and Obstetrics, Podhale Multidisciplinary Hospital, 34-400 NowyTarg, Poland."}, {"Identifier": [], "Affiliation": "Division of Perinatology and Women's Diseases, Poznan University of Medical Sciences, Polna 33, 60-535 Poznan, Poland."}], "LastName": "Wolski", "ForeName": "Hubert", "Initials": "H"}, {"Identifier": ["0000-0001-6599-9204"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chair and Department of Medical Microbiology, Pozna\u0144 University of Medical Sciences, Wieniawskiego 3, 61-712 Poznan, Poland."}], "LastName": "Karpi\u0144ski", "ForeName": "Tomasz M", "Initials": "TM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Phytochemistry, Institute of Natural Fibres and Medicinal Plants, Kolejowa 2, 62-064 Plewiska, Poland."}, {"Identifier": [], "Affiliation": "Division of Perinatology and Women's Diseases, Poznan University of Medical Sciences, Polna 33, 60-535 Poznan, Poland."}], "LastName": "Seremak-Mrozikiewicz", "ForeName": "Agnieszka", "Initials": "A"}], "GrantList": [{"GrantID": "2017/25/B/NZ7/02741", "Agency": "the Polish Ministry of Science and Higher Education, National Science Centre in Poland", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Flavonoids"}, {"RegistryNumber": "0", "NameOfSubstance": "HIF1A protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Hypoxia-Inducible Factor 1, alpha Subunit"}, {"RegistryNumber": "0", "NameOfSubstance": "PGF protein, human"}, {"RegistryNumber": "144589-93-5", "NameOfSubstance": "Placenta Growth Factor"}, {"RegistryNumber": "56LH93261Y", "NameOfSubstance": "Methyldopa"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Cell Line"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Flavonoids"}, {"QualifierName": ["drug effects"], "DescriptorName": "Gene Expression Regulation"}, {"QualifierName": [], "DescriptorName": "Human Umbilical Vein Endothelial Cells"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["genetics"], "DescriptorName": "Hypoxia-Inducible Factor 1, alpha Subunit"}, {"QualifierName": [], "DescriptorName": "In Vitro Techniques"}, {"QualifierName": ["drug therapy", "genetics", "pathology"], "DescriptorName": "Inflammation"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Methyldopa"}, {"QualifierName": ["drug effects", "pathology"], "DescriptorName": "Placenta"}, {"QualifierName": ["genetics"], "DescriptorName": "Placenta Growth Factor"}, {"QualifierName": [], "DescriptorName": "Pregnancy"}, {"QualifierName": ["drug effects"], "DescriptorName": "Trophoblasts"}, {"QualifierName": ["drug therapy", "genetics", "pathology"], "DescriptorName": "Vascular Diseases"}], "CoiStatement": "The authors declare that they have no competing interests."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Tinawi M. Hypertension in pregnancy. Arch. Intern. Med. Res. 2020;3:10\u201317. doi: 10.26502/aimr.0018.", "ArticleIdList": ["10.26502/aimr.0018"]}, {"Citation": "O\u017carowski M., Miko\u0142ajczak P.\u0141., Kujawski R., Wielgus K., Klejewski A., Wolski H., Seremak-Mrozikiewicz A. Pharmacological effect of quercetin in hypertension and its potential application in pregnancy-induced hypertension: Review of in vitro, in vivo, and clinical studies. Evid. Based Complement. Alternat. Med. 2018;2018:1\u201319. doi: 10.1155/2018/7421489.", "ArticleIdList": ["10.1155/2018/7421489", "PMC6304490", "30622610"]}, {"Citation": "Duley L. The global impact of pre-eclampsia and eclampsia. Semin. Perinatol. 2009;33:130\u2013137. doi: 10.1053/j.semperi.2009.02.010.", "ArticleIdList": ["10.1053/j.semperi.2009.02.010", "19464502"]}, {"Citation": "S\u00e1nchez-Aranguren L.C., Prada C.E., Ria\u00f1o-Medina C.E., Lopez M. Endothelial dysfunction and preeclampsia: Role of oxidative stress. Front. Physiol. 2014;5:372. doi: 10.3389/fphys.2014.00372.", "ArticleIdList": ["10.3389/fphys.2014.00372", "PMC4193194", "25346691"]}, {"Citation": "Rana S., Lemoine E., Granger J.P., Karumanchi S.A. Preeclampsia: Pathophysiology, challenges, and perspectives. Circ. Res. 2019;124:1094\u20131112. doi: 10.1161/CIRCRESAHA.118.313276.", "ArticleIdList": ["10.1161/CIRCRESAHA.118.313276", "30920918"]}, {"Citation": "Karumanchi S.A. Angiogenic factors in preeclampsia: From diagnosis to therapy. Hypertension. 2016;67:1072\u20131079. doi: 10.1161/HYPERTENSIONAHA.116.06421.", "ArticleIdList": ["10.1161/HYPERTENSIONAHA.116.06421", "27067718"]}, {"Citation": "Roberts J.M., Hubel C.A. The two stage model of preeclampsia: Variations on the theme. Placenta. 2009;30:S32\u2013S37. doi: 10.1016/j.placenta.2008.11.009.", "ArticleIdList": ["10.1016/j.placenta.2008.11.009", "PMC2680383", "19070896"]}, {"Citation": "Lam C., Lim K.H., Karumanchi S.A. Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia. Hypertension. 2005;46:1077\u20131085. doi: 10.1161/01.HYP.0000187899.34379.b0.", "ArticleIdList": ["10.1161/01.HYP.0000187899.34379.b0", "16230516"]}, {"Citation": "Myatt L., Webster R.P. Vascular biology of preeclampsia. J. Thromb. Haemost. 2009;7:375\u2013384. doi: 10.1111/j.1538-7836.2008.03259.x.", "ArticleIdList": ["10.1111/j.1538-7836.2008.03259.x", "19087223"]}, {"Citation": "Zhou Y., McMaster M., Woo K., Janatpour M., Perry J., Karpanen T., Alitalo K., Damsky C., Fisher S.J. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am. J. Pathol. 2002;160:1405\u20131423. doi: 10.1016/S0002-9440(10)62567-9.", "ArticleIdList": ["10.1016/S0002-9440(10)62567-9", "PMC3277330", "11943725"]}, {"Citation": "Liberis A., Stanulov G., Ali C.E., Hassan A., Pagalos A., Kontomanolis E.N. Pre-eclampsia and the vascular endothelial growth factor: A new aspect. Clin. Exp. Obstet.Gynecol. 2016;43:9\u201313.", "ArticleIdList": ["27048010"]}, {"Citation": "Cornelius D.C. Preeclampsia: From inflammation to immunoregulation. Clin. Med. Insights Blood Disord. 2018;11:1\u20136. doi: 10.1177/1179545X17752325.", "ArticleIdList": ["10.1177/1179545X17752325", "PMC5772493", "29371787"]}, {"Citation": "Perucci L.O., Corr\u00eaa M.D., Dusse L.M., Gomes K.B., Sousa L.P. Resolution of inflammation pathways in preeclampsia\u2014A narrative review. Immunol. Res. 2017;65:774\u2013789. doi: 10.1007/s12026-017-8921-3.", "ArticleIdList": ["10.1007/s12026-017-8921-3", "28391374"]}, {"Citation": "Schaefer C., Peters P., Miller R.K. Drugs during Pregnancy and Lactation. Treatment Options and Risk Assessment. Elsevier; Oxford, UK: 2007."}, {"Citation": "Cooper W.O., Hernandez-Diaz S., Arbogast P.G., Dudley J.A., Dyer S., Gideon P.S., Hall K., Ray W.A. Major congenital malformations after first-trimester exposure to ACE inhibitors. N. Engl. J. Med. 2006;354:2443\u20132451. doi: 10.1056/NEJMoa055202.", "ArticleIdList": ["10.1056/NEJMoa055202", "16760444"]}, {"Citation": "Seremak-Mrozikiewicz A., Drews K. Methyldopa in therapy of hypertension in pregnant women. Ginekol. Pol. 2004;75:160\u2013165.", "ArticleIdList": ["15108591"]}, {"Citation": "Picaud A., Walter P., de Preville G., Nicolas P. Fatal toxic hepatitis in pregnancy. A discuss the role of methyldopa. J. Gynecol. Obstet. Biol. Reprod. (Paris) 1990;19:192\u2013196.", "ArticleIdList": ["2324442"]}, {"Citation": "Lowe S.A., Rubin P.C. The pharmacological management of hypertension in pregnancy. J. Hypertens. 1992;10:201\u2013207. doi: 10.1097/00004872-199203000-00001.", "ArticleIdList": ["10.1097/00004872-199203000-00001", "1315815"]}, {"Citation": "Sibai B.M. Treatment of hypertension in pregnant women. N. Engl. J. Med. 1996;335:257\u2013265. doi: 10.1056/NEJM199607253350407.", "ArticleIdList": ["10.1056/NEJM199607253350407", "8657243"]}, {"Citation": "Caton A.R., Bell E.M., Druschel C.M., Werler M.M., Lin A.E., Browne M.L., McNutt L.A., Romitti P.A., Mitchell A.A., Olney R.S., et al. National birth defects prevention study. Antihypertensive medication use during pregnancy and the risk of cardiovascular malformations. Hypertension. 2009;54:63\u201370. doi: 10.1161/HYPERTENSIONAHA.109.129098.", "ArticleIdList": ["10.1161/HYPERTENSIONAHA.109.129098", "PMC4913772", "19433779"]}, {"Citation": "Xie R.H., Guo Y., Krewski D., Mattison D., Nerenberg K., Walker M.C., Wen S.W. Trends in using \u03b2-blockers and methyldopa for hypertensive disorders during pregnancy in a Canadian population. Eur. J. Obstet. Gynecol. Reprod. Biol. 2013;171:281\u2013285. doi: 10.1016/j.ejogrb.2013.09.032.", "ArticleIdList": ["10.1016/j.ejogrb.2013.09.032", "24139131"]}, {"Citation": "Adrover R. Hepatotoxicity from alfa-methyldopa during pregnancy: Two case reports. J. Clin. Gastroenterol. Treat. 2016;2:1\u20133. doi: 10.23937/2469-584X/1510031.", "ArticleIdList": ["10.23937/2469-584X/1510031"]}, {"Citation": "Aldomet (Methyldopa) Side Effects.  [(accessed on 26 February 2021)]; Available online:  https://www.rxlist.com/aldomet-side-effects-drug-center.htm."}, {"Citation": "Smith D.K., Lennon R.P., Carlsgaard P.B. Managing hypertension using combination therapy. Am. Fam. Physician. 2020;101:341\u2013349.", "ArticleIdList": ["32163253"]}, {"Citation": "Singh P., Mishra A., Goswami S., Singh A., Tiwari K.D. Hypertension and herbal plant for its treatment: A review. Indian, J. Res. Pharm. Biotech. 2015;3:358\u2013366."}, {"Citation": "Adamczak A., O\u017carowski M., Karpi\u0144ski T.M. Antibacterial activity of some flavonoids and organic acids widely distributed in plants. J. Clin. Med. 2019;9:109. doi: 10.3390/jcm9010109.", "ArticleIdList": ["10.3390/jcm9010109", "PMC7019947", "31906141"]}, {"Citation": "Roy M.K., Nakahara K., Na T.V., Trakoontivakorn G., Takenaka M., Isobe S., Tsushida T. Baicalein, a flavonoid extracted from a methanolic extract of Oroxylum indicum inhibits proliferation of a cancer cell line in vitro via induction of apoptosis. Pharmazie. 2007;62:149\u2013153.", "ArticleIdList": ["17341037"]}, {"Citation": "Fujita M., Shiota S., Kuroda T., Hatano T., Yoshida T., Mizushima T., Tsuchiya T. Remarkable synergies between baicalein and tetracycline, and baicalein and \u03b2-lactams against methicillin-resistant Staphylococcus aureus. Microbiol. Immunol. 2005;49:391\u2013396. doi: 10.1111/j.1348-0421.2005.tb03732.x.", "ArticleIdList": ["10.1111/j.1348-0421.2005.tb03732.x", "15840965"]}, {"Citation": "He S., Dong X., Zhang G., Fan W., Duan S., Shi H., Li D., Li R., Chen G., Long G., et al. High quality genome of Erigeron breviscapus provides a reference for herbal plants in Asteraceae. Mol. Ecol. Resour. 2021;21:153\u2013169. doi: 10.1111/1755-0998.13257.", "ArticleIdList": ["10.1111/1755-0998.13257", "PMC7756436", "32985109"]}, {"Citation": "Anand David A.V., Arulmoli R., Parasuraman S. Overviews of Biological Importance of Quercetin: A Bioactive Flavonoid. Pharmacogn. Rev. 2016;10:84\u201389. doi: 10.4103/0973-7847.194044.", "ArticleIdList": ["10.4103/0973-7847.194044", "PMC5214562", "28082789"]}, {"Citation": "Salehi B., Venditti A., Sharifi-Rad M., Kr\u0119giel D., Sharifi-Rad J., Durazzo A., Lucarini M., Santini A., Souto E.B., Novellino E., et al. The Therapeutic Potential of Apigenin. Int. J. Mol. Sci. 2019;20:1305. doi: 10.3390/ijms20061305.", "ArticleIdList": ["10.3390/ijms20061305", "PMC6472148", "30875872"]}, {"Citation": "Mani R., Natesan V. Chrysin: Sources, beneficial pharmacological activities, and molecular mechanism of action. Phytochemistry. 2018;145:187\u2013196. doi: 10.1016/j.phytochem.2017.09.016.", "ArticleIdList": ["10.1016/j.phytochem.2017.09.016", "29161583"]}, {"Citation": "Fang P., Yu M., Shi M., Bo P., Gu X., Zhang Z. Baicalin and its aglycone: A novel approach for treatment of metabolic disorders. Pharmacol. Rep. 2020;72:13\u201323. doi: 10.1007/s43440-019-00024-x.", "ArticleIdList": ["10.1007/s43440-019-00024-x", "32016847"]}, {"Citation": "Li Y., Song K., Zhang H., Yuan M., An N., Wei Y., Wang L., Sun Y., Xing Y., Gao Y. Anti-inflammatory and immunomodulatory effects of baicalin in cerebrovascular and neurological disorders. Brain Res. Bull. 2020;164:314\u2013324. doi: 10.1016/j.brainresbull.2020.08.016.", "ArticleIdList": ["10.1016/j.brainresbull.2020.08.016", "32858128"]}, {"Citation": "Chledzik S., Strawa J., Matuszek K., Nazaruk J. Pharmacological effects of scutellarin, an active component of genus Scutellaria and Erigeron: A systematic review. Am. J. Chin. Med. 2018;46:319\u2013337. doi: 10.1142/S0192415X18500167.", "ArticleIdList": ["10.1142/S0192415X18500167", "29433387"]}, {"Citation": "O\u017carowski M., Kujawski R., Miko\u0142ajczak P.\u0141., Wielgus K., Klejewski A., Wolski H., Seremak-Mrozikiewicz A. In vitro and in vivo activities of flavonoids\u2014apigenin, baicalin, chrysin, scutellarin\u2014in regulation of hypertension\u2014a review for their possible effects in pregnancy\u2013induced hypertension. Herba Pol. 2019;65:55\u201370. doi: 10.2478/hepo-2019-0001.", "ArticleIdList": ["10.2478/hepo-2019-0001"]}, {"Citation": "Kennedy D.A., Lupattelli A., Koren G., Nordeng H. Herbal medicine use in pregnancy: Results of a multinational study. BMC Complement. Altern. Med. 2013;13:1\u201310. doi: 10.1186/1472-6882-13-355.", "ArticleIdList": ["10.1186/1472-6882-13-355", "PMC4029224", "24330413"]}, {"Citation": "John L.J., Shantakumari N. Herbal medicines use during pregnancy: A review from the Middle East. Oman Med. J. 2015;30:229\u2013236. doi: 10.5001/omj.2015.48.", "ArticleIdList": ["10.5001/omj.2015.48", "PMC4561638", "26366255"]}, {"Citation": "Orendi K., Kivity V., Sammar M., Grimpel Y., Gonen R., Meiri H., Lubzens E., Huppertz B. Placental and trophoblastic in vitro models to study preventive and therapeutic agents for preeclampsia. Placenta. 2011;32:S49\u2013S54. doi: 10.1016/j.placenta.2010.11.023.", "ArticleIdList": ["10.1016/j.placenta.2010.11.023", "21257083"]}, {"Citation": "Xu B., Nakhla S., Makris A., Hennessy A. TNF-alfa inhibits trophoblast integration into endothelial cellular networks. Placenta. 2011;32:241\u2013246. doi: 10.1016/j.placenta.2010.12.005.", "ArticleIdList": ["10.1016/j.placenta.2010.12.005", "21215448"]}, {"Citation": "Zhu A., Romero R., Huang J.B., Clark A., Petty H.R. Maltooligosaccharides from JEG-3 trophoblast-like cells exhibit immunoregulatory properties. Am. J. Reprod. Immunol. 2011;65:54\u201364. doi: 10.1111/j.1600-0897.2010.00851.x.", "ArticleIdList": ["10.1111/j.1600-0897.2010.00851.x", "PMC3059513", "20455875"]}, {"Citation": "Zhang Y., Liu H., Shi X., Qiao F., Zeng W., Feng L., Deng D., Liu H., Wu Y. Maspin impairs the function of endothelial cells: An implying pathway of preeclampsia. BMC Pregnancy Childbirth. 2017;17:328. doi: 10.1186/s12884-017-1525-z.", "ArticleIdList": ["10.1186/s12884-017-1525-z", "PMC5622509", "28962595"]}, {"Citation": "Kus G., Ozkurt M., Kabadere S., Erkasap N., Goger G., Demirci F. Antiproliferative and antiapoptotic effect of thymoquinone on cancer cells in vitro. Bratisl. Lek. Listy. 2018;119:312\u2013316. doi: 10.4149/BLL_2018_059.", "ArticleIdList": ["10.4149/BLL_2018_059", "29749248"]}, {"Citation": "Harmon A.C., Cornelius D.C., Amaral L.M., Faulkner J.L., Cunningham M.W., Jr., Wallace K., LaMarca B. The role of inflammation in the pathology of preeclampsia. Clin. Sci. 2016;130:409\u2013419. doi: 10.1042/CS20150702.", "ArticleIdList": ["10.1042/CS20150702", "PMC5484393", "26846579"]}, {"Citation": "Michalczyk M., Celewicz A., Celewicz M., Wo\u017aniakowska-Gondek P., Rzepka R. The Role of Inflammation in the Pathogenesis of Preeclampsia. Mediators Inflamm. 2020;2020:3864941. doi: 10.1155/2020/3864941.", "ArticleIdList": ["10.1155/2020/3864941", "PMC7556088", "33082708"]}, {"Citation": "Alijotas-Reig J., Esteve-Valverde E., Ferrer-Oliveras R., Llurba E., Gris J.M. Tumor necrosis factor-alfa and pregnancy: Focus on biologics. An updated and comprehensive review. Clin. Rev. Allergy Immunol. 2017;53:40\u201353. doi: 10.1007/s12016-016-8596-x.", "ArticleIdList": ["10.1007/s12016-016-8596-x", "28054230"]}, {"Citation": "Xu B., Bobek G., Makris A., Hennessy A. Antihypertensive methyldopa, la\u03b2lol, hydralazine, and clonidine reversed tumour necrosis factor-\u03b1 inhibited endothelial nitric oxide synthase expression in endothelial-trophoblast cellular networks. Clin. Exp. Pharmacol. Physiol. 2017;44:421\u2013427. doi: 10.1111/1440-1681.12712.", "ArticleIdList": ["10.1111/1440-1681.12712", "27998008"]}, {"Citation": "Rinehart B.K., Terrone D.A., Lagoo-Deenadayalan S., Barber W.H., Hale E.A., Martin J.N., Bennett W.A. Expression of the placental cytokines tumor necrosis factor \u03b1, interleukin 1\u03b2, and interleukin 10 is increased in preeclampsia. Am. J. Obstet. Gynecol. 1999;181:915\u2013920. doi: 10.1016/S0002-9378(99)70325-X.", "ArticleIdList": ["10.1016/S0002-9378(99)70325-X", "10521753"]}, {"Citation": "Amash A., Holcberg G., Sapir O., Huleihel M. Placental secretion of interleukin-1 and interleukin-1 receptor antagonist in preeclampsia: Effect of magnesium sulfate. J. Interferon Cytokine Res. 2012;32:432\u2013441. doi: 10.1089/jir.2012.0013.", "ArticleIdList": ["10.1089/jir.2012.0013", "PMC3438822", "22909148"]}, {"Citation": "Romero R., Gotsch F., Pineles B., Kusanovic J.P. Inflammation in pregnancy: Its roles in reproductive physiology, obstetrical complications, and fetal injury. Nutr. Rev. 2007;65:S194\u2013S202. doi: 10.1301/nr.2007.dec.S194-S202.", "ArticleIdList": ["10.1301/nr.2007.dec.S194-S202", "18240548"]}, {"Citation": "Southcombe J.H., Redman C.W., Sargent I.L., Granne I. Interleukin-1 family cytokines and their regulatory proteins in normal pregnancy and pre-eclampsia. Clin. Exp. Immunol. 2015;181:480\u2013490. doi: 10.1111/cei.12608.", "ArticleIdList": ["10.1111/cei.12608", "PMC4557384", "25693732"]}, {"Citation": "Opsjon S.L., Austgulen R., Waage A. Interleukin-1, interleukin-6 and tumor necrosis factor at delivery in preeclamptic disorders. Acta Obstet. Gynecol. Scand. 1995;74:19\u201326. doi: 10.3109/00016349509009937.", "ArticleIdList": ["10.3109/00016349509009937", "7856428"]}, {"Citation": "Stallmach T., Hebisch G., Joller H., Kolditz P., Engelmann M. Expression pattern of cytokines in the different compartments of the feto-maternal unit under various conditions. Reprod. Fertil. Dev. 1995;7:1573\u20131580. doi: 10.1071/RD9951573.", "ArticleIdList": ["10.1071/RD9951573", "8743167"]}, {"Citation": "Keelan J.A., Mitchell M.D. Placental cytokines and preeclampsia. Front. Biosci. 2007;12:2706\u20132727. doi: 10.2741/2266.", "ArticleIdList": ["10.2741/2266", "17127274"]}, {"Citation": "Lockwood C.J., Yen C.F., Basar M., Kayisli U.A., Martel M., Buhimschi I., Buhimschi C., Huang S.J., Krikun G., Schatz F. Preeclampsia-related inflammatory cytokines regulate interleukin-6 expression in human decidual cells. Am. J. Pathol. 2008;172:1571\u20131579. doi: 10.2353/ajpath.2008.070629.", "ArticleIdList": ["10.2353/ajpath.2008.070629", "PMC2408417", "18467705"]}, {"Citation": "Omere C., Richardson L., Saade G.R., Bonney E.A., Kechichian T., Menon R. Interleukin (IL)-6: A friend or foe of pregnancy and parturition? Evidence from functional studies in fetal membrane cells. Front. Physiol. 2020;11:891. doi: 10.3389/fphys.2020.00891.", "ArticleIdList": ["10.3389/fphys.2020.00891", "PMC7397758", "32848846"]}, {"Citation": "Wang H., Chen M., Sang X., You X., Wang Y., Paterson I.C., Hong W., Yang X. Development of small molecule inhibitors targeting TGF-\u03b2 ligand and receptor: Structures, mechanism, preclinical studies and clinical usage. Eur. J. Med. Chem. 2020;191:112154. doi: 10.1016/j.ejmech.2020.112154.", "ArticleIdList": ["10.1016/j.ejmech.2020.112154", "32092587"]}, {"Citation": "Tirado-Rodriguez B., Ortega E., Segura-Medina P., Huerta-Yepez S. TGF-\u03b2: An important mediator of allergic disease and a molecule with dual activity in cancer development. J. Immunol. Res. 2014;2014:1\u201315. doi: 10.1155/2014/318481.", "ArticleIdList": ["10.1155/2014/318481", "PMC4071855", "25110717"]}, {"Citation": "Muy-Rivera M., Sanchez S.E., Vadachkoria S., Qiu C., Bazul V., Williams M.A. Transforming growth factor-\u03b21 (TGF-\u03b21) in plasma is associated with preeclampsia risk in Peruvian women with systemic inflammation. Am. J. Hypertens. 2004;17:334\u2013338. doi: 10.1016/j.amjhyper.2003.12.010.", "ArticleIdList": ["10.1016/j.amjhyper.2003.12.010", "15062887"]}, {"Citation": "Xiang W., Xu X., Chen H. Expression of TGF-\u03b2l in placenta of the patients with pregnancy-induced hypertension and its relationship with serum VCAM-1. J. Huazhong Univ. Sci. Technolog. Med. Sci. 2005;25:82\u201384. doi: 10.1007/BF02831394.", "ArticleIdList": ["10.1007/BF02831394", "15934316"]}, {"Citation": "Alam S., Ahmad S., Zafeer F., Rizvi A.A., Gulati R., Rashid S. Role of Tgf-\u03921 in the pathogenesis of pre-eclampsia. Ann. Int. Med. Den. Res. 2017;3:PH01\u2013PH04. doi: 10.21276/aimdr.2017.3.3.PH1.", "ArticleIdList": ["10.21276/aimdr.2017.3.3.PH1"]}, {"Citation": "Jena M.K., Sharma N.R., Petitt M., Maulik D., Nayak N.R. Pathogenesis of preeclampsia and therapeutic approaches targeting the placenta. Biomolecules. 2020;10:953. doi: 10.3390/biom10060953.", "ArticleIdList": ["10.3390/biom10060953", "PMC7357118", "32599856"]}, {"Citation": "Juwita D.R., Yulistiani Y., Zarkaty M.E. Effects of methyldopa on VEGF levels as proangiogenic factor in severe pre-eclampsia at Haji hospital, Surabaya. Fol. Med. Indones. 2017;53:267\u2013271. doi: 10.20473/fmi.v53i4.7159.", "ArticleIdList": ["10.20473/fmi.v53i4.7159"]}, {"Citation": "Ren Y., Wang H., Qin H., Yang J., Wang Y., Jiang S., Pan Y. Vascular Endothelial Growth Factor expression in peripheral blood of patients with pregnancy induced hypertension syndrome and its clinical significance. Pak. J. Med. Sci. 2014;30:634\u2013637. doi: 10.12669/pjms.303.4558.", "ArticleIdList": ["10.12669/pjms.303.4558", "PMC4048521", "24948994"]}, {"Citation": "Duhig K.E., Seed P.T., Myers J.E., Bahl R., Bambridge G., Barnfield S., Ficquet J., Girling J.C., Khalil A., Shennan A.H., et al. Placental growth factor testing for suspected pre-eclampsia: A cost-effectiveness analysis. BJOG. 2019;126:1390\u20131398. doi: 10.1111/1471-0528.15855.", "ArticleIdList": ["10.1111/1471-0528.15855", "PMC6771855", "31240854"]}, {"Citation": "Krauss T., Pauer H.U., Augustin H.G. Prospective analysis of placenta growth factor (PlGF) concentrations in the plasma of women with normal pregnancy and pregnancies complicated by preeclampsia. Hypertens. Pregnancy. 2004;23:101\u2013111. doi: 10.1081/PRG-120028286.", "ArticleIdList": ["10.1081/PRG-120028286", "15117604"]}, {"Citation": "Khalil A., Muttukrishna S., Harrington K., Jauniaux E. Effect of antihypertensive therapy with \u03b1 methyldopa on levels of angiogenic factors in pregnancies with hypertensive disorders. PLoS ONE. 2008;3:e2766. doi: 10.1371/journal.pone.0002766.", "ArticleIdList": ["10.1371/journal.pone.0002766", "PMC2447877", "18648513"]}, {"Citation": "Tal R. The role of hypoxia and hypoxia-inducible factor-1\u03b1 in preeclampsia pathogenesis. Biol. Reprod. 2012;87:134. doi: 10.1095/biolreprod.112.102723.", "ArticleIdList": ["10.1095/biolreprod.112.102723", "23034156"]}, {"Citation": "Iriyama T., Wang W., Parchim N.F., Song A., Blackwell S.C., Sibai B.M., Kellems R.E., Xia Y. Hypoxia-independent upregulation of placental hypoxia inducible factor-1\u03b1 gene expression contributes to the pathogenesis of preeclampsia. Hypertension. 2015;65:1307\u20131315. doi: 10.1161/HYPERTENSIONAHA.115.05314.", "ArticleIdList": ["10.1161/HYPERTENSIONAHA.115.05314", "PMC4859813", "25847948"]}, {"Citation": "Caniggia I., Grisaru-Gravnosky S., Kuliszewsky M., Post M., Lye S.J. Inhibition of TGF-\u03b2 3 restores the invasive capability of extravillous trophoblasts in preeclamptic pregnancies. J. Clin. Investig. 1999;103:1641\u20131650. doi: 10.1172/JCI6380.", "ArticleIdList": ["10.1172/JCI6380", "PMC408387", "10377170"]}, {"Citation": "Kim S.Y., Park S.Y., Lim J.H., Lee B.Y., Yang J.H., Ryu H.M. Hypoxia inducible factor-1\u03b1 (HIF-1\u03b1) gene polymorphisms in Korean patients with preeclampsia. J. Endocrinol. Invest. 2012;35:670\u2013675. doi: 10.3275/8009.", "ArticleIdList": ["10.3275/8009", "21979130"]}, {"Citation": "Juskowiak B., Bogacz A., Wolek M., Kami\u0144ski A., Uzar I., Seremak-Mrozikiewicz A., Czerny B. Expression profiling of genes modulated by rosmarinic acid (RA) in MCF-7 breast cancer cells. Ginekol. Pol. 2018;89:541\u2013545. doi: 10.5603/GP.a2018.0092.", "ArticleIdList": ["10.5603/GP.a2018.0092", "30393841"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "1", "Day": "6"}, {"Year": "2021", "Month": "2", "Day": "16"}, {"Year": "2021", "Month": "2", "Day": "22"}, {"Year": "2021", "Month": "3", "Day": "3", "Hour": "1", "Minute": "1"}, {"Year": "2021", "Month": "3", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "4", "Day": "7", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "2", "Day": "26"}], "PublicationStatus": "epublish", "ArticleIdList": ["33652665", "PMC7956652", "10.3390/molecules26051259", "molecules26051259"]}}], "PubmedBookArticle": []}